Kurzfassung

A single-arm, international, multi-center trial investaigation the efficacy and safety of ofatumumab treatmant and maintenence treatment in patients with B-Cell chronic lymphocytic who progressed following response or stable disease after ofatumumab treatment in Hx-CD20-406